The Fiction Behind The Cost of New Drugs
The following column appeared yesterday in The Fiscal Times: The following column…
Questions for FDA, NIH on Failure to Publish Clinical Trial Data
Hat tip to FDAWebview: Three leading Democratic Congressmen are wondering why companies…
A Von Eschenbach Sighting
Former Food and Drug Administration commissioner Andrew Von Eschenbach, who ran the…
Unintended Pregnancy: A Biomarker for Disease and Poverty
The U.S. Catholic Conference of Bishops proved in its late Friday statement…
Racing to Nowhere: The Susan B Komen Foundation
I had dinner over the weekend with a close friend who is…
FDA Fired Device Whistleblowers
The Food and Drug Administration fired six device division reviewers after they…
Stents for Stroke Prevention A Risky Proposition
Sen. Mark Kirk, Republican of Illinois, suffered a debilitating stroke on Monday,…
Avastin for Colon Cancer: A Conflicted View
In the long-running war to hold down health care spending, controlling cancer…
A Theory on Why The FDA Hid Conflicts of Interest
Much has been made of Health and Human Services Secretary Kathleen Sebelius’…
No Savings from Raising Medicare Age
The Congressional Budget Office released an issue brief Tuesday that suggested lifting…